| 產(chǎn)品編號(hào) | bs-2037PA |
| 英文名稱 | Streptomycin/OVA |
| 中文名稱 | 鏈霉素偶聯(lián)雞卵白蛋白 |
 | Specific References (1) | bs-2037PA has been referenced in 1 publications. [IF=2.965] Wang Xiaolei. et al. Inhibition of miRNA-155 Alleviates High Glucose-Induced Podocyte Inflammation by Targeting SIRT1 in Diabetic Mice. J Diabetes Res. 2021;2021:5597394 Other ; |
| 理論分子量 | N/AkDa |
| 性 狀 | Liquid |
| 物 種 | N/A |
| 序 列 | Coupling protein |
| 內(nèi)毒素 | Not analyzed |
| 活性 | No |
| 標(biāo)簽 | N/A |
| 緩 沖 液 | 0.01M TBS(pH7.4) |
| 保存條件 | Stored at -70℃ or -20℃. Avoid repeated freeze/thaw cycles. |
| 產(chǎn)品介紹 | Streptomycin is an antibiotic produced by soil bacteria of the genus Streptomyces and is active against both gram positive and gram negative bacteria, including species resistant to other antibiotics, eg some streptococci, penicillin resistant staphylococci, and bacteria of the genera Proteus and Pseudomonas. Originally isolated by Selman A. Waksman and Albert Schatz in 1947, streptomycin is effective against tubercle bacilli and is a mainstay of tuberculosis therapy. Because streptomycin resistant tubercle bacilli emerge during treatment, the antibiotic is usually used in combination with one or more of the drugs isoniazid, ethambutol, and aminosalicylic acid. Streptomycin acts by inhibiting protein synthesis and damaging cell membranes in susceptible microorganisms. Possible side effects include injury to the kidneys and nerve damage that can result in dizziness and deafness. |
我要詢價(jià)
*聯(lián)系方式：
(可以是QQ、MSN、電子郵箱、電話等，您的聯(lián)系方式不會(huì)被公開)
*內(nèi)容：
